Press Releases
-
Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022
Business WireLearn More -
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Business WireLearn More -
Mammoth Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases
Business WireLearn More -
Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
Business WireLearn More -
Mammoth Biosciences Named to Fierce Medtech’s “Fierce 15” Companies of 2020 for Advancing Next Generation CRISPR Products in Diagnostics and Therapeutics
WebWireLearn More -
Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms
WebWireLearn More -